Company: SINT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010496
Chunk: 61

Company: Sintx Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 1
Chunk 61
---
We are not aware of any pending or threatened legal
proceeding against us that could have a material adverse effect on our business, operating results or financial condition. The medical
device industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property
rights as well as improper hiring practices. As a result, we may be involved in various legal proceedings from time to time.

Item 1A.
Risk Factors

Information regarding risk factors appears in Item
1A of our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on March 19, 2025. There have
been no material changes from the risk factors previously disclosed in the Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS

On February 20, 2025, the Company entered into a private placement transaction
pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors
for aggregate gross proceeds of $5.0 million, before deducting fees to the placement agent and other expenses payable by the Company in
connection with the Private Placement. For a more detailed description of the transaction reference is made to the Form 8-K filed by the
Company with the Securities and Exchange Commission on February 26, 2025.

Share
Repurchase Program

    Issuer Purchase of Equity Securities
  
    Period 
    (a) Total number of shares purchased (1)  
    (b) Average price paid per share (1)  
    (c ) Total number of shares purchased as part of publicly announced plans or programs (1)  
    (d) Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs (1) 
  
    01/01/25 – 01/31/25 
     -  
    $-  
     -  
    $500,000.00 
  
    02/01/25 – 02/28/25 
     -  
     -  
     -  
    $500,000.00 
  
    03/01/25 – 03/31/25 
     29,665  
    $2.91  
     29,665  
    $413,736.72 

    Total